Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT06542796

Study on the Classification of Comprehensive Treatment Effect of Hepatocellular Carcinoma

Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2025-02-10

100

Participants Needed

1

Research Sites

138 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Through a retrospective study of patients who underwent comprehensive treatment for hepatocellular carcinoma at the Second Affiliated Hospital of Zhejiang University, we explored the risk factors related to the sensitivity of comprehensive treatment. We used the PD-L1 expression level of patients before comprehensive treatment,characteristic morphology of tertiary lymphoid structures, as well as other parameters, are used to construct a liver cancer comprehensive treatment efficacy evaluation model. Using this liver cancer comprehensive treatment efficacy evaluation model, we conducted a randomized controlled trial on whether to receive comprehensive treatment for liver cancer patients to verify the accuracy and practical value of the model.

CONDITIONS

Official Title

Study on the Classification of Comprehensive Treatment Effect of Hepatocellular Carcinoma

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with advanced hepatocellular carcinoma
  • Aged between 18 and 75 years
Not Eligible

You will not qualify if you...

  • Have severe diabetes, heart failure, or liver and/or kidney failure
  • Have a history of schizophrenia
  • Have a history of other malignant tumors or metastatic liver tumors discovered after surgery
  • Received anti-tumor drugs for other diseases
  • Pregnant or lactating women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

2ndAffiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, China, 310009

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here